Form D · Biotechnology
BioNADrx Holdings, Inc.
Johnson City, TN · CIK 0002009791
Offering snapshot reported Jan 30, 2024 · SEC filing
- Reported sold
- $125K Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 30, 2024 | Initial | $125,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503839
Source: Form D, filed Jan 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Wendy Kormac | Director, Executive |
| Phillip Mansour | Director |
| Filip Pinter | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
207 N. Boone Street, Suite 15
Johnson City, TN, 37604
Johnson City, TN, 37604